Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Biomarkers for the Study of Sarcopenia and Its Evolution in Diabetic Patients.

NCT05783700 is registered in ClinicalTrials.gov with Esther Soler as lead sponsor.

NCT NCT05783700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05783700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Biomarkers for the Study of Sarcopenia and Its Evolution in Diabetic Patients.
Lead sponsor
Esther Soler
Phase
Observational
Overall status
Unknown status
Start date
October 2, 2023
Completion date
January 7, 2024
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic foot, metabolic syndrome, neuropathy, diabetic, sarcopenia, vascular disease, peripheral